Best Researcher Award
Evangelos Cholongitas, Laiko General Hospital of Athens, Greece
The Best Researcher Award recognizes the scholarly achievements and scientific contributions of Evangelos Cholongitas, a clinician and academic researcher affiliated with the Laiko General Hospital of Athens in Greece. His work in hepatology has contributed to the advancement of liver disease management, transplantation medicine, portal hypertension research, and evidence-based clinical hepatology.[1] Through a substantial body of peer-reviewed publications, citation impact, and international collaboration, Cholongitas has established a recognized academic profile within gastroenterology and liver research communities.[2]
Abstract
Evangelos Cholongitas is recognized for sustained contributions to hepatology and liver transplantation research. His scientific work has addressed major clinical challenges related to chronic liver disease, portal hypertension, transplantation outcomes, renal impairment in liver disorders, and evidence-based therapeutic approaches. The Best Researcher Award acknowledges his academic productivity, citation influence, and continuing role in advancing translational and clinical hepatology research within international scientific communities.[1]
Keywords
Hepatology, Liver Transplantation, Gastroenterology, Chronic Liver Disease, Clinical Research, Portal Hypertension, Hepatic Disorders, Evidence-Based Medicine, Liver Failure, Academic Research Excellence
Introduction
Hepatology remains an important medical discipline focused on the diagnosis, management, and prevention of liver-related diseases. Research in this area contributes significantly to improving patient outcomes in cirrhosis, viral hepatitis, liver transplantation, metabolic liver disease, and hepatocellular carcinoma.[4] Evangelos Cholongitas has contributed extensively to these areas through clinical studies, systematic reviews, and collaborative investigations that support evidence-based hepatology practice.[2]
Research Profile
Evangelos Cholongitas has developed a comprehensive academic profile in hepatology with research interests spanning liver transplantation, chronic liver disease, portal hypertension, and transplantation-associated complications. His publication portfolio includes peer-reviewed journal articles, collaborative studies, and evidence synthesis reports indexed in international academic databases.[1]
Research Contributions
The research contributions of Evangelos Cholongitas are associated with clinically relevant investigations into liver disease progression, transplantation outcomes, and complications associated with hepatic dysfunction. His studies frequently evaluate diagnostic indicators, patient survival factors, renal impairment in liver disease, and post-transplant clinical management.
Publications
Evangelos Cholongitas has contributed to numerous publications in hepatology and transplantation medicine. Representative publication themes include chronic liver disease management, transplantation outcomes, renal dysfunction in cirrhosis, and portal hypertension research.[4]
Research Impact
The scholarly impact of Evangelos Cholongitas is reflected in his extensive citation metrics, publication output, and h-index performance within hepatology-related scientific literature. Citation indicators demonstrate sustained engagement with his research findings across international academic and clinical communities.[1]
Award Suitability
The Best Researcher Award recognizes measurable academic influence, scholarly productivity, and sustained scientific engagement. Evangelos Cholongitas demonstrates these criteria through a combination of publication activity, international citation impact, and contributions to clinically relevant hepatology research.
Conclusion
Evangelos Cholongitas has contributed substantially to hepatology and transplantation medicine through sustained clinical research, publication activity, and evidence-based scientific investigations. His scholarly work addresses important aspects of chronic liver disease management and transplantation outcomes, supporting advancements in patient care and academic hepatology.[2] Recognition through the Best Researcher Award reflects his continuing role in international liver disease research and academic medicine.
External Links
References
1. Elsevier. (n.d.). Scopus author details: Evangelos Cholongitas (Author ID: 55399959500). Scopus. https://www.scopus.com/authid/detail.uri?authorId=55399959500
2. Google Scholar. (n.d.). Evangelos Cholongitas citation profile.
https://scholar.google.com/citations?user=Mur4BnEAAAAJ&hl=en
3. Marelli, L., Stigliano, R., Triantos, C., Senzolo, M., Cholongitas, E., Davies, N., Tibballs, J., Meyer, T., Patch, D. W., & Burroughs, A. K. (2007). Transarterial therapy for hepatocellular carcinoma: Which technique is more effective? A systematic review of cohort and randomized studies. CardioVascular and Interventional Radiology, 30(1), 6–25. https://doi.org/10.1007/s00270-006-0062-3
4. Tsochatzis, E. A., Gurusamy, K. S., Ntaoula, S., Cholongitas, E., Davidson, B. R., & Burroughs, A. K. (2011). Elastography for the diagnosis of severity of fibrosis in chronic liver disease: A meta-analysis of diagnostic accuracy. Journal of Hepatology.
https://doi.org/10.1016/j.jhep.2010.07.033
5. Cholongitas, E., Papatheodoridis, G. V., Vangeli, M., Terreni, N., Patch, D., & Burroughs, A. K. (2006). Systematic review: The model for end-stage liver disease—Should it replace Child-Pugh’s classification for assessing prognosis in cirrhosis? Alimentary Pharmacology & Therapeutics, 24(6), 859–870.
https://doi.org/10.1111/j.1365-2036.2005.02691.x